Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.

Company Overview and News

Challenging outlook seen for construction in 2H18

2018-07-18 theedgemarkets
Construction sector Maintain neutral: Post-14th general election, the new Pakatan Harapan government embarked on a review of all megaprojects, as promised in its election manifesto. The Kuala Lumpur-Singapore high-speed rail (RM60 billion to RM70 billion) and mass rapid transit Line 3 (MRT3) (RM40 billion) were shelved shortly thereafter. Although there were reports regarding the revival of these projects, we reckon that chances are slim in the near term.
9261 5843 3204 5797 5072 7014 9679 7078 5056

Bursa opens higher against trend

2018-07-17 malaymail
KUALA LUMPUR, July 17 — Bursa Malaysia opened higher this morning, despite the mixed global and regional performances of peers as well as overnight trade on Wall Street.
PBLOF UPBMF 5819 BATS 4162 1295 BSMAF 2089 7078 1818

Ahmad Zaki Resources sees improved bottom line for FY18

2018-06-29 theedgemarkets
KUALA LUMPUR: Ahmad Zaki Resources Bhd (AZRB) is anticipating a positive outlook and an improved bottom line for the financial year ending Dec 31, 2018 (FY18), on the back of ongoing projects and better performance from its plantation division.
BSMAF 7078 1818

AZRB anticipates better bottomline in FY18

2018-06-28 theedgemarkets
KUALA LUMPUR (June 28): Ahmad Zaki Resources Bhd (AZRB) anticipates a positive outlook and better bottomline figure for the financial year ending Dec 31, 2018 (FY18), on the back of ongoing projects and improvement in the plantation division.
BSMAF 7078 1818

Sapura Energy, RHB, Bina Darulaman, Daya Materials, Metronic Global, Meda Inc and Gas Malaysia

2018-06-11 theedgemarkets
KUALA LUMPUR (June 11): Based on corporate announcements and news flow today, companies in focus on Tuesday (June 12) may include: Sapura Energy Bhd, RHB Bank Bhd, Bina Darulaman Bhd, Daya Materials Bhd, Metronic Global Bhd, Meda Inc Bhd and Gas Malaysia Bhd.
4634 6173 5209 0091 BSMAF 0043 7078 1818

Metronic Global awarded RM5m in adjudication proceedings against Ahmad Zaki

2018-06-11 theedgemarkets
KUALA LUMPUR (June 11): Metronic Global Bhd‘s wholly-owned subsidiary Metronic Engineering Sdn Bhd has been awarded 4.73 million Saudi Arabian riyals (RM5 million) in an adjudication proceeding against Ahmad Zaki Resources Bhd.
BSMAF 0043 7078 1818

Local funds shore up volatile market

REVIEW: Bursa Malaysia in the post-election week reflected investor sentiment over the polling results with a show of confidence by local institutions keeping the market in good stead.
GMALY 3204 5226 PBLOF 4715 GMALF BATS 4162 1295 BSMAF 7078 1818

Stocks battered by GE14 tsunami

The unprecedented electoral victory by Pakatan Harapan was unfavourable to many stocks as it was favourable to others.
3204 BSMAF 0065 7078 1818

AZRB secures RM198mil job from PNB Merdeka Ventures

PETALING JAYA: Ahmad Zaki Resources Bhd (AZRB) has been awarded a RM197.96mil construction contract by PNB Merdeka Ventures Sdn Bhd.
BSMAF 7078 1818

Toll dilemma

PETALING JAYA: With the Government expected to make announcements on changes to toll charges on expressways, attention will be focused on the impact this may have on concessionaires and the national finances.
5932 6645 7078

Day of volatile trading on Bursa Malaysia

PETALING JAYA: Several politically-linked stocks on Bursa Malaysia went on a wild ride yesterday, driven by the market volatility in the first day of trading post-14th general election (GE14).
0035 5738 BSMAF 7078 1818

Stocks on the radar

Possible M&A: Shareholding changes suggest that Alliance Bank could be poised for an M&A down the road.
2488 3204 5226 7889 7078

Related Articles

REPH: Recro Pharma Analysis and Research Report

2018-08-20 - Asif

Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...

ACHN: Achillion Pharmaceuticals Analysis and Research Report

2018-08-20 - Asif

Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...

BTE: Baytex Energy Trust Analysis and Research Report

2018-08-20 - Asif

General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="